Griesinger, F., Pérol, M., Girard, N., Durand-Zaleski, I., Zacharias, S., Bosquet, L., Jänicke, M., Quantin, X., Groth, A., Fleitz, A., Calleja, A., Patel, S., Lacoin, L., Daumont, M. J., Penrod, J. R., Carroll, R., Waldenberger, D., Reynaud, D., Thomas, M., & Chouaid, C. (2022). impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. Lung cancer, 172, 65–74. http://access.bl.uk/ark:/81055/vdc_100164727351.0x00005d